Cancer Monthly has the results of cancer treatments used at over 260 leading cancer hospitals and medical centers in the U.S., Europe, Canada, Asia, and Australia. Aarhus University Hospital Academic Hospital Aichi Cancer Center Hospital
(Rafay); North Hampshire Hospitals, Basingstroke, England (D. L. Rawaf); University College London Hospitals, London, England (D. L. Rawaf); WHO Collaborating Centre, Imperial College of London, London, England (D. L. Rawaf); Golestan Research Center of Gastroenterology and Hepatology, ...
During the interview, Elaine shares how the organization feeds pediatric oncology patients in the Tennessee hospitals, give financial aid to families with kids fighting cancer, and focus on raising awareness and funds for childhood cancer research. She talks about their two main events,RALLY IN THE ...
Residents of Metropolitan Nashville, Tennessee, dying from primary cancer of the liver, as well as those with this disease diagnosed in Nashville hospitals, over a 17-year period along with their age-, sex-, and race-matched controls have had interview data collected to identify background ...
(D. L. Rawaf); University College London Hospitals, London, England, United Kingdom (D. L. Rawaf); Academic Public Health, Public Health England, London, England, United Kingdom (S. Rawaf); School of Social Sciences and Psychology, Western Sydney University, Penrith, New South Wales, ...
66, 70-72 Determinants of CPM include White race, younger age, higher socioeconomic status, and treatment facilities that are teaching hospitals or provide breast reconstruction.72 CPM increases cost and morbidity and has not been shown to improve survival. Most women with stage III disease are ...
as well as advocating for the patient's values and goals and helping transition patients from hospitals back to their homes. Supportive psychology teams offer therapy and counseling to cancer patients, their families, and caregivers. Integrative oncology and nutrition teams focus on nu...
Somatic mutations in cancer genomes are caused by multiple mutational processes, each of which generates a characteristic mutational signature1. Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium2 of the International Cancer Gen
Ascertainment of Prostate Cancer Diagnosis, Recurrence, and Death After a participant reported a diagnosis of prostate cancer, medical records and pathology reports were sought from treating physicians and hospitals to confirm the diagnosis and obtain information on pathology, treatments, prostate-specific...
Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium Barbara Brouwers & Hans Wildiers Comprehensive Cancer Center The Netherlands, Utrecht, The Netherlands Lambertus A Kiemeney & Katja K Aben Department of Epidemiology, Biostatistics and Health Techn...